ライフサイエンスコーパス: molecular diagnostics

1 ion studies, signalling pathway analysis and molecular diagnostics.

2 computation and as applied as point-of-care molecular diagnostics.

3 development of true point-of-care tests for molecular diagnostics.

4 logy applications related to targeted enzyme molecular diagnostics.

5 can cause ocular inflammation by serology or molecular diagnostics.

6 ge of potential applications in clinical and molecular diagnostics.

7 at potential for biomedical applications and molecular diagnostics.

8 g as well as emerging approaches in clinical molecular diagnostics.

9 ovides more 'tools' for DNA manipulation and molecular diagnostics.

10 which is of great interest in genotyping and molecular diagnostics.

11 ation is becoming increasingly important for molecular diagnostics.

12 testing, and management are all dependent on molecular diagnostics.

13 DNA sample before sequencing is critical in molecular diagnostics.

14 resolution, providing a robust platform for molecular diagnostics.

15 cacies, have recently become supplemented by molecular diagnostics.

16 iation, disease susceptibility, and clinical molecular diagnostics.

17 to a number of applications in the field of molecular diagnostics.

18 e disease genes has allowed establishment of molecular diagnostics.

19 ed in many fields of biomedical research and molecular diagnostics.

20 leic acid sequences is a major bottleneck in molecular diagnostics.

21 ow-complexity, highly sensitive and accurate molecular diagnostics.

22 ially an important clinical marker in cancer molecular diagnostics.

23 sequences yield unique genome signatures for molecular diagnostics.

24 nomics revolution (e.g., microarrays) and of molecular diagnostics.

25 biology and is poised to enter the field of molecular diagnostics.

26 ll also greatly assist in drug discovery and molecular diagnostics.

27 bes makes this method attractive for routine molecular diagnostics.

28 ation to guide therapy and, potentially, for molecular diagnostics.

29 acter stool antigen CIDTs versus culture and molecular diagnostics.

30 rs, promising a new wave of simple and rapid molecular diagnostics.

31 nomics, small genome sequencing and clinical molecular diagnostics.

32 ith the naked eye is seemingly impossible in molecular diagnostics.

33 provide inexpensive and accessible advanced molecular diagnostics.

34 sents a breakthrough shift into a new era of molecular diagnostics.

35 verse range of DNA or RNA viruses by routine molecular diagnostics.

36 ent ability to exploit the full potential of molecular diagnostics.

37 lead to a versatile and portable device for molecular diagnostics.

38 ated with the clinical adoption of WGS-based molecular diagnostics.

39 n most HCCs and provides a unique target for molecular diagnostics.

40 They have been approved as therapeutics and molecular diagnostics.

41 ntially useful as bright contrast agents for molecular diagnostics.

42 h-throughput polymerase chain reaction (PCR) molecular diagnostics, a method was developed to rapidly

43 ents will include simpler and less expensive molecular diagnostics, advances in the understanding of

44 pment of miniaturized analytical systems for molecular diagnostics and beyond.

45 hat scientific and technological advances in molecular diagnostics and bioinformatics are well integr

46 Molecular diagnostics and biomarker discovery should ben

47 e potential to offer simple sample-to-answer molecular diagnostics and can inform healthcare workers

48 ility and virulence and could render current molecular diagnostics and countermeasures ineffective.

49 genetic variants with phenotype improve both molecular diagnostics and drug discovery and offer clini

50 Molecular diagnostics and early assessment of treatment

51 nal efforts focused on using these tools for molecular diagnostics and for the discovery of therapeut

52 d cancer; new approaches in chemoprevention, molecular diagnostics and genetic testing, and therapy;

53 This method can be widely useful as molecular diagnostics and genomic technologies become ro

54 reagents, and amplify detection signals for molecular diagnostics and imaging.

55 antibody testing, transplantation pathology, molecular diagnostics and laboratory support for the inc

56 A brief discussion of molecular diagnostics and possible safety concerns is al

57 ogy research and the development of improved molecular diagnostics and prevention schemes for this ne

58 o these findings, including the prospects of molecular diagnostics and rational therapeutics.

59 DNA at surfaces and interfaces ranging from molecular diagnostics and sequencing to biosensing.

60 noninvasive methods of diagnosis as well as molecular diagnostics and their merits and shortcomings

61 tion patterns has major potential to advance molecular diagnostics and underpin research investigatio

62 proaches, including applications of advanced molecular diagnostics and vaccine probe studies, as well

63 EOC, and consequently may serve as important molecular diagnostics and/or therapeutic targets for the

64 a robust pipeline of new tools, particularly molecular diagnostics, and well over 50 companies active

65 the goals of understanding their genomes for molecular diagnostics applications, vaccine redevelopmen

66 nable to identify active state of infection, molecular diagnostics are an effective means to detect Z

67 which could lead to amplification bias when molecular diagnostics are applied for L. pneumophila det

68 d the potential impact of EATR strategies on molecular diagnostics are discussed.

69 Molecular diagnostics are of increasing importance when

70 Nucleic acid-based molecular diagnostics are particularly well suited for t

71 order to counter the common perception that molecular diagnostics are too complicated to work in low

72 as major implications for the future of both molecular diagnostics as well as cancer chemotherapy.

73 nostics and protein analysis, cell handling, molecular diagnostics, as well as food, water, and soil

74 l to enable single cell studies for advanced molecular diagnostics, as well as wider applications in

75 or obstacles to implement nucleic acid-based molecular diagnostics at the point-of-care (POC) and in

76 Molecular diagnostics based on the polymerase chain reac

77 ave important applications in ultrasensitive molecular diagnostics, bioterrorism agent detection, and

78 studies designed to help evaluate new rapid molecular diagnostics by developing, testing, and applyi

79 Point-of-care molecular diagnostics can provide efficient and cost-eff

80 oration of D-cycloserine resistance in novel molecular diagnostics could allow for targeted use of th

81 Innovative molecular diagnostics deployed in the clinic enable new

82 Medical Director, Clinical Microbiology and Molecular Diagnostics, Dynacare Laboratories, and Froedt

83 Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencin

84 With rapid molecular diagnostics emerging in clinical microbiology

85 which would not be detected by current rapid molecular diagnostics employed in South Africa that asse

86 Molecular diagnostics enable rapid and simplified diagno

87 Molecular diagnostics enable sensitive detection of resp

88 ast data in combination with advancements in molecular diagnostics enables much greater precision in

89 pplications related to analytical chemistry, molecular diagnostics, environmental monitoring, and nat

90 red gene circuits, bring new capabilities to molecular diagnostics, expanding the molecular detection

91 Individual omics-wide molecular diagnostics, extracorporeal therapies, and dru

92 e systems for nematode-pest-crop management: molecular diagnostics for nematode identification, genet

93 The value of rapid, panel-based molecular diagnostics for positive blood culture bottles

94 ection could allow the development of rapid, molecular diagnostics for sCJD and has implications for

95 assays has resulted in the increased use of molecular diagnostics for the routine detection of HSV i

96 has played a major role in the transition of molecular diagnostics from research to routine clinical

97 properties spanning the fields of chemistry, molecular diagnostics, gene regulation, medicine, and ma

98 Molecular diagnostics has generated substantial dividend

99 The field of molecular diagnostics has greatly decreased the time it

100 The widespread use of multiplex molecular diagnostics has led to a significant increase

101 re than a century, the recent development of molecular diagnostics has shed new light on the origin a

102 Rapid molecular diagnostics have great potential to limit the

103 Recently, emerging molecular diagnostics have met requirements for speed, l

104 Molecular diagnostics, however, have been difficult to i

105 otechnology and will have profound impact on molecular diagnostics, imaging and therapeutics.

106 setting, this study shows the potential for molecular diagnostics in ADPKD that is likely to become

107 importance of an epidemiological history and molecular diagnostics in ascertaining insights into tran

108 strong contender for versatile and portable molecular diagnostics in both research and clinical sett

109 y of employing a sample pooling strategy for molecular diagnostics in clinical and epidemiologic mala

110 l practice can improve drug use by providing molecular diagnostics in concert with molecular therapeu

111 es on the relative merits of 3 approaches to molecular diagnostics in hematologic malignancies: indic

112 The utility of molecular diagnostics in invasive fungal infections is d

113 y provides a comprehensive assessment of PZA molecular diagnostics in M/XDR TB cases.

114 of next generation sequencing platforms for molecular diagnostics in non-small-cell lung cancer is i

115 lecular programming in general and DNA-based molecular diagnostics in particular.

116 ies continue to be driven by developments in molecular diagnostics in pediatric genitourinary tumors.

117 t practical limitations to the deployment of molecular diagnostics in the field and demonstrates how

118 rtant implications for the interpretation of molecular diagnostics, including identifying patients at

119 cine has engendered a need for corresponding molecular diagnostics, including noninvasive molecular i

120 . influenzae in CSF, and that application of molecular diagnostics is a feasible way to enhance local

121 rying nanoceria in the lab and point-of-care molecular diagnostics is anticipated.

122 espoke diagnosis and treatment, this area of molecular diagnostics is beginning to see an upsurge in

123 Molecular diagnostics is crucial for prevention, identif

124 Molecular diagnostics is progressing from low-throughput

125 Molecular diagnostics is typically outsourced to well-eq

126 To challenge the ability of our molecular diagnostics laboratory to use whole-genome seq

127 occur prior to the arrival of specimens in a molecular diagnostics laboratory.

128 c evaluation, cyst fluid analysis, and novel molecular diagnostics, many of these lesions remain diff

129 uture work with contact tracing and advanced molecular diagnostics may allow for identification of MR

130 The expense inherent to molecular diagnostics may be an overriding concern for a

131 demiologic investigation in conjunction with molecular diagnostics may enable early identification of

132 Expense inherent to molecular diagnostics may prevent laboratories from util

133 Expense inherent to molecular diagnostics may prevent laboratories from util

134 In addition, new molecular diagnostics now permit rapid detection of drug

135 Mutation-based molecular diagnostics of autosomal dominant polycystic k

136 f growing practical interest with respect to molecular diagnostics of cancer, infectious and genetic

137 ations of this sampling methodology to rapid molecular diagnostics of cutaneous allergies and infecti

138 aCGH), the most commonly used technology for molecular diagnostics of genomic disorders.

139 ive, accurate and sensitive alternatives for molecular diagnostics of MDR- and XDR-TB.

140 This finding has important implications for molecular diagnostics of PMD.

141 iency is associated with muscular dystrophy, molecular diagnostics of the plectin gene provides progn

142 Molecular diagnostics offer an increase in sensitivity f

143 rization based on guidelines, utilization of molecular diagnostics, particularly kinase domain mutati

144 Recent advances in molecular diagnostics, pathobiology, and developmental t

145 For molecular diagnostics, primers were designed from the ca

146 As part of our molecular diagnostics program, we have now encountered f

147 l & Melinda Gates Foundation Next Generation Molecular Diagnostics Project.

148 ning methods to modern synthetic biology and molecular diagnostics protocols.

149 rchers and clinicians to perform multiplexed molecular diagnostics quickly and easily.

150 ased RFLP to make it a faster format, DuPont Molecular Diagnostics recently introduced the IS6110-Pvu

151 Current approaches to molecular diagnostics rely heavily on PCR amplification

152 e of the limited signal-to-background ratio, molecular diagnostics requires molecular amplification o

153 At present, rapid molecular diagnostics (RMDs) that can identify this phen

154 istance, particularly katG p.Ser315Thr, into molecular diagnostics should enable targeted treatment o

155 ein assays, which are highly sought after in molecular diagnostics such as cancer diagnosis and treat

156 nd fully automated Beckman Coulter DxN Veris Molecular Diagnostics System (DxN Veris System) was eval

157 ostics system is also known as the Veris MDx molecular diagnostics system and the Veris MDx system.).

158 eliminary results of a portable and low-cost molecular diagnostics system for ZIKV infection are repo

159 The DxN Veris molecular diagnostics system is also known as the Veris

160 w, fully automated Beckman Coulter DxN Veris molecular diagnostics system was evaluated at 10 Europea

161 ancer treatment, the growing availability of molecular diagnostics techniques may help in identifying

162 chemistry and detection continue to improve molecular diagnostics technology, blood samples are stil

163 ights into disease pathogenesis, and lead to molecular diagnostics that can be used to optimize the t

164 Therefore, molecular diagnostics that include markers for rifampici

165 Molecular diagnostics that rapidly and accurately predic

166 Molecular diagnostics that rapidly and accurately predic

167 practice of oncology is being transformed by molecular diagnostics that will enable predictive and pe

168 Despite advances in molecular diagnostics, the ability to rapidly diagnose M

169 Despite the advancement of rapid molecular diagnostics, the use of plate cultures inocula

170 ides a novel way for molecular therapies and molecular diagnostics to come together in the discovery

171 I) to establish and monitor hypomyelination, molecular diagnostics to determine a specific etiology,

172 , to develop novel diagnostic techniques and molecular diagnostics, to establish a program for identi

173 Recently, Luminex Molecular Diagnostics (Toronto, Canada) developed 23 ana

174 Traditional technologies for molecular diagnostics using blood are limited to laborat

175 tral to modern molecular biology and also to molecular diagnostics where identification of a particul

176 /strain level discrimination, is critical in molecular diagnostics with major impacts in areas such a

177 med a direct comparative analysis of current molecular diagnostics with WGS.

178 The availability of rapid and reliable molecular diagnostics would therefore aid future studies